BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33940194)

  • 1. Nitric-oxide releasing chitosan nanoparticles towards effective treatment of cutaneous leishmaniasis.
    Cabral FV; Pelegrino MT; Seabra AB; Ribeiro MS
    Nitric Oxide; 2021 Sep; 113-114():31-38. PubMed ID: 33940194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-loaded chitosan nanoparticles as an innovative antileishmanial platform.
    Cabral FV; Pelegrino MT; Sauter IP; Seabra AB; Cortez M; Ribeiro MS
    Nitric Oxide; 2019 Dec; 93():25-33. PubMed ID: 31541732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis.
    Riezk A; Van Bocxlaer K; Yardley V; Murdan S; Croft SL
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32887341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-leishmanial activity of a topical miltefosine gel in experimental models of New World cutaneous leishmaniasis.
    Neira LF; Mantilla JC; Escobar P
    J Antimicrob Chemother; 2019 Jun; 74(6):1634-1641. PubMed ID: 30815688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment of L. major infected BALB/c mice with a novel diselenide chitosan hydrogel formulation.
    Schwartz J; Moreno E; Fernández C; Navarro-Blasco I; Nguewa PA; Palop JA; Irache JM; Sanmartín C; Espuelas S
    Eur J Pharm Sci; 2014 Oct; 62():309-16. PubMed ID: 24964292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.
    Paladi Cde S; Pimentel IA; Katz S; Cunha RL; Judice WA; Caires AC; Barbiéri CL
    PLoS Negl Trop Dis; 2012; 6(5):e1626. PubMed ID: 22616018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study.
    Monzote L; Montalvo AM; Scull R; Miranda M; Abreu J
    Biomed Pharmacother; 2007; 61(2-3):148-53. PubMed ID: 17254746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
    Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
    J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice.
    Moreno E; Schwartz J; Larrea E; Conde I; Font M; Sanmartín C; Irache JM; Espuelas S
    Nanomedicine; 2015 Nov; 11(8):2003-12. PubMed ID: 26282379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice.
    Godinho JL; Simas-Rodrigues C; Silva R; Ürmenyi TP; de Souza W; Rodrigues JC
    Int J Antimicrob Agents; 2012 Apr; 39(4):326-31. PubMed ID: 22226653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis.
    Garnier T; Brown MB; Lawrence MJ; Croft SL
    J Pharm Pharmacol; 2006 Aug; 58(8):1043-54. PubMed ID: 16872550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of ascaridole, carvacrol, and caryophyllene oxide against Leishmania.
    Pastor J; García M; Steinbauer S; Setzer WN; Scull R; Gille L; Monzote L
    Acta Trop; 2015 May; 145():31-8. PubMed ID: 25697866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmanicidal activity of Himatanthus sucuuba latex against Leishmania amazonensis.
    Soares DC; Andrade AL; Delorenzi JC; Silva JR; Freire-de-Lima L; Falcão CA; Pinto AC; Rossi-Bergmann B; Saraiva EM
    Parasitol Int; 2010 Jun; 59(2):173-7. PubMed ID: 20096374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.
    Aguiar MG; Pereira AM; Fernandes AP; Ferreira LA
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4699-704. PubMed ID: 20713665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of nanoemulsion with Pterodon emarginatus Vogel oleoresin for topical treatment of cutaneous leishmaniasis.
    Kawakami MYM; Zamora LO; Araújo RS; Fernandes CP; Ricotta TQN; de Oliveira LG; Queiroz-Junior CM; Fernandes AP; da Conceição EC; Ferreira LAM; Barros ALB; Aguiar MG; Oliveira AEMFM
    Biomed Pharmacother; 2021 Feb; 134():111109. PubMed ID: 33341050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice.
    Bavarsad N; Fazly Bazzaz BS; Khamesipour A; Jaafari MR
    Acta Trop; 2012 Oct; 124(1):33-41. PubMed ID: 22750480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis.
    Trinconi CT; Reimão JQ; Coelho AC; Uliana SR
    J Antimicrob Chemother; 2016 May; 71(5):1314-22. PubMed ID: 26851606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N
    Present C; Girão RD; Lin C; Caljon G; Van Calenbergh S; Moreira O; Ruivo LAS; Batista MM; Azevedo R; Batista DDGJ; Soeiro MNC
    Parasitology; 2024 Apr; 151(5):506-513. PubMed ID: 38533610
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.
    Mussi SV; Fernandes AP; Ferreira LA
    Parasitol Res; 2007 May; 100(6):1221-6. PubMed ID: 17206508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.